Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zai Lab LtdZLAB · Entity 4271 | Director · Chairperson & CEO | July 01, 2026 | July 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zai Lab Ltd
Report date July 01, 2026 · Filed July 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| American Depositary SharesSEC Table I · non-derivative | Direct | 1,221,401 |
Last balance in matching sequence
After 2026-07-02 transaction · row 4
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
4 source rowsRow 1 · 2026-07-01 · Exercise / conversion · Acquired 18,000 · Balance 1,221,784 F1: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2: ADSs acquired upon vesting of Restricted Share Units ("RSUs"). F3: Each RSU represents a contingent right to receive one ADS. Row 2 · 2026-07-01 · Tax withholding · Disposed 7,083 · Balance 1,214,701 F1: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F4: These ADSs were withheld to cover taxes upon vesting of RSUs. Row 3 · 2026-07-02 · Exercise / conversion · Acquired 11,048 · Balance 1,225,749 F1: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2: ADSs acquired upon vesting of Restricted Share Units ("RSUs"). F3: Each RSU represents a contingent right to receive one ADS. Row 4 · 2026-07-02 · Tax withholding · Disposed 4,348 · Balance 1,221,401 F1: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F4: These ADSs were withheld to cover taxes upon vesting of RSUs. |
| Restricted Share UnitsSEC Table II · derivative / convertible security | Direct | 36,000 |
Reported balance
After 2026-07-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-07-01 · Exercise / conversion · Disposed 18,000 · Balance 36,000 F3: Each RSU represents a contingent right to receive one ADS. F5: The RSUs vest in equal annual installments over four years beginning on 07/01/2025, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F1: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. |
| Restricted Share UnitsSEC Table II · derivative / convertible security | Direct | 33,146 |
Reported balance
After 2026-07-02 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-07-02 · Exercise / conversion · Disposed 11,048 · Balance 33,146 F3: Each RSU represents a contingent right to receive one ADS. F6: The RSUs vest in equal annual installments over four years beginning on 07/02/2026, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F1: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. |
| Restricted Share UnitsSEC Table II · derivative / convertible security | Direct | 80,393 |
Reported balance
After 2026-07-02 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-07-02 · Grant · Acquired 80,393 · Balance 80,393 F3: Each RSU represents a contingent right to receive one ADS. F7: The RSUs vest in equal annual installments over four years beginning on 07/02/2027, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F1: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. |
Filing footnotes · ownership attribution and instrument terms
F1: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
F2: ADSs acquired upon vesting of Restricted Share Units ("RSUs").
F3: Each RSU represents a contingent right to receive one ADS.
F4: These ADSs were withheld to cover taxes upon vesting of RSUs.
F5: The RSUs vest in equal annual installments over four years beginning on 07/01/2025, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered in the form of ADSs to the reporting person following vesting.
F6: The RSUs vest in equal annual installments over four years beginning on 07/02/2026, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered in the form of ADSs to the reporting person following vesting.
F7: The RSUs vest in equal annual installments over four years beginning on 07/02/2027, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered in the form of ADSs to the reporting person following vesting.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 12, 2025 Filed May 13, 2025 20:48 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionAmerican Depositary Shares | 50,000 | $0.60 | $30,000.00 |
DisclosureSEC source: 0000905148-25-001597 · form4.xml · nonDerivative · entry 4 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 529,851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| May 09, 2025 Filed May 13, 2025 20:48 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionStock Options (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0000905148-25-001597 · form4.xml · derivative · entry 7 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 342,776 Underlying: American Depositary Shares · 50,000 shares Expires 2025-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The Stock Options fully vested as of October 22, 2020. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| May 09, 2025 Filed May 13, 2025 20:48 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleAmerican Depositary Shares | 3,638 | $30.16 | $109,738.45 |
DisclosureSEC source: 0000905148-25-001597 · form4.xml · nonDerivative · entry 3 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 479,851 F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2024. F4 · price: Reflects a weighted average sale price of $30.1645 per share, at prices ranging from $30.125 to $30.24 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 09, 2025 Filed May 13, 2025 20:48 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleAmerican Depositary Shares | 46,362 | $29.58 | $1,371,401.87 |
DisclosureSEC source: 0000905148-25-001597 · form4.xml · nonDerivative · entry 2 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 483,489 F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2024. F3 · price: Reflects a weighted average sale price of $29.5803 per share, at prices ranging from $29.125 to $30.12 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 09, 2025 Filed May 13, 2025 20:48 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionAmerican Depositary Shares | 50,000 | $0.60 | $30,000.00 |
DisclosureSEC source: 0000905148-25-001597 · form4.xml · nonDerivative · entry 1 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 529,851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| April 04, 2025 Filed Apr 7, 2025 20:48 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleAmerican Depositary Shares | 2,945 | $33.11 | $97,503.06 |
DisclosureSEC source: 0000905148-25-001115 · form4.xml · nonDerivative · entry 2 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 479,851 F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F4 · shares: These ADSs were sold automatically to cover taxes upon vesting of RSUs. Read SEC document |
| April 03, 2025 Filed Apr 7, 2025 20:48 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionRestricted Share Units · Derivative | 6,750 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-001115 · form4.xml · derivative · entry 3 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,250 Underlying: American Depositary Shares · 6,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ADS. F5 · derivative.exercise_date: The RSUs vest in equal annual installments over four years beginning on 04/03/2025, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F5 · derivative.expiration_date: The RSUs vest in equal annual installments over four years beginning on 04/03/2025, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| April 03, 2025 Filed Apr 7, 2025 20:48 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionAmerican Depositary Shares | 6,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000905148-25-001115 · form4.xml · nonDerivative · entry 1 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 482,796 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · shares: ADSs acquired upon vesting of Restricted Share Units ("RSUs"). F3 · price: Each RSU represents a contingent right to receive one ADS. Read SEC document |
| April 02, 2025 Filed Apr 3, 2025 21:07 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleAmerican Depositary Shares | 5,808 | $35.89 | $208,472.35 |
DisclosureSEC source: 0000905148-25-001080 · form4.xml · nonDerivative · entry 3 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 476,046 F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F4 · shares: These ADSs were sold automatically to cover taxes upon vesting of RSUs. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 21:07 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionRestricted Share Units · Derivative | 3,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-001080 · form4.xml · derivative · entry 5 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,400 Underlying: American Depositary Shares · 3,400 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ADS. F6 · derivative.exercise_date: The RSUs vest in equal annual installments over five years beginning on 04/01/2022, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F6 · derivative.expiration_date: The RSUs vest in equal annual installments over five years beginning on 04/01/2022, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 21:07 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionRestricted Share Units · Derivative | 10,800 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-001080 · form4.xml · derivative · entry 4 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,600 Underlying: American Depositary Shares · 10,800 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ADS. F5 · derivative.exercise_date: The RSUs vest in equal annual installments over five years beginning on 04/01/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F5 · derivative.expiration_date: The RSUs vest in equal annual installments over five years beginning on 04/01/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 21:07 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionAmerican Depositary Shares | 3,400 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000905148-25-001080 · form4.xml · nonDerivative · entry 2 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 481,854 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · shares: ADSs acquired upon vesting of Restricted Share Units ("RSUs"). F3 · price: Each RSU represents a contingent right to receive one ADS. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 21:07 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionAmerican Depositary Shares | 10,800 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000905148-25-001080 · form4.xml · nonDerivative · entry 1 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 478,454 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · shares: ADSs acquired upon vesting of Restricted Share Units ("RSUs"). F3 · price: Each RSU represents a contingent right to receive one ADS. Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 21:05 UTC | Zai Lab Ltd ZLAB · Entity 4271 | GiftAmerican Depositary Shares | 6,521 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-000947 · form4.xml · nonDerivative · entry 4 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 467,654 F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · kind: This transaction represents a bona fide charitable contribution as a gift to a donor advisory fund. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 21:05 UTC | Zai Lab Ltd ZLAB · Entity 4271 | GiftAmerican Depositary Shares | 3,885 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-000947 · form4.xml · nonDerivative · entry 3 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 474,175 F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F4 · kind: This transaction represents the transfer of shares held by the reporting person to a trust established for the benefit of an adult son of the reporting person. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 21:05 UTC | Zai Lab Ltd ZLAB · Entity 4271 | GiftAmerican Depositary Shares | 10,406 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-000947 · form4.xml · nonDerivative · entry 2 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 478,060 F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F3 · kind: This transaction represents the transfer of shares held by the reporting person to a trust established for the benefit of an adult son of the reporting person. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 21:05 UTC | Zai Lab Ltd ZLAB · Entity 4271 | GiftAmerican Depositary Shares | 5,651 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-000947 · form4.xml · nonDerivative · entry 1 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 488,466 F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · kind: This transaction represents a bona fide charitable contribution as a gift to a donor advisory fund. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 20:26 UTC | Zai Lab Ltd ZLAB · Entity 4271 | GrantRestricted Share Units · Derivative | 10,620 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-000907 · form4.xml · derivative · entry 2 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,620 Underlying: American Depositary Shares · 10,620 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Share Unit ("RSU") represents a contingent right to receive one ADS. F4 · derivative.exercise_date: The RSUs vest in equal annual installments over four years beginning on 03/10/2026, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F4 · derivative.expiration_date: The RSUs vest in equal annual installments over four years beginning on 03/10/2026, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 20:26 UTC | Zai Lab Ltd ZLAB · Entity 4271 | GrantStock Options (Right to Buy) · Derivative | 252,585 | $0.00 Strike: $34.69 | $0.00 |
DisclosureSEC source: 0000905148-25-000907 · form4.xml · derivative · entry 1 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 252,585 Underlying: American Depositary Shares · 252,585 shares Expires 2035-03-10 F2 · derivative.exercise_date: The option vests in equal annual installments over four years beginning on 03/10/2026, the first anniversary of the date of grant, subject to continuous service. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| March 05, 2025 Filed Mar 6, 2025 21:20 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionStock Options (Right to Buy) · Derivative | 46,389 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0000905148-25-000872 · form4.xml · derivative · entry 9 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 392,776 Underlying: American Depositary Shares · 46,389 shares Expires 2025-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The Stock Options fully vested as of October 22, 2020. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| March 05, 2025 Filed Mar 6, 2025 21:20 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleAmerican Depositary Shares | 25,296 | $35.84 | $906,682.00 |
DisclosureSEC source: 0000905148-25-000872 · form4.xml · nonDerivative · entry 7 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 494,117 F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2024. F7 · price: Reflects a weighted average sale price of $35.8429 per share, at prices ranging from $35.58 to $36.11 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 05, 2025 Filed Mar 6, 2025 21:20 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleAmerican Depositary Shares | 21,093 | $35.20 | $742,439.85 |
DisclosureSEC source: 0000905148-25-000872 · form4.xml · nonDerivative · entry 6 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 519,413 F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2024. F6 · price: Reflects a weighted average sale price of $35.1984 per share, at prices ranging from $34.58 to $35.575 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 05, 2025 Filed Mar 6, 2025 21:20 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionAmerican Depositary Shares | 46,389 | $0.60 | $27,833.40 |
DisclosureSEC source: 0000905148-25-000872 · form4.xml · nonDerivative · entry 5 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 540,506 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 21:20 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionStock Options (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0000905148-25-000872 · form4.xml · derivative · entry 8 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 439,165 Underlying: American Depositary Shares · 50,000 shares Expires 2025-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The Stock Options fully vested as of October 22, 2020. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 21:20 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleAmerican Depositary Shares | 5,583 | $33.99 | $189,743.28 |
DisclosureSEC source: 0000905148-25-000872 · form4.xml · nonDerivative · entry 4 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 494,117 F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2024. F5 · price: Reflects a weighted average sale price of $33.9859 per share, at prices ranging from $33.93 to $34.07 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 21:20 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleAmerican Depositary Shares | 37,752 | $33.55 | $1,266,579.60 |
DisclosureSEC source: 0000905148-25-000872 · form4.xml · nonDerivative · entry 3 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 499,700 F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2024. F4 · price: Reflects a weighted average sale price of $33.5500 per share, at prices ranging from $32.93 to $33.92 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 21:20 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleAmerican Depositary Shares | 6,665 | $32.69 | $217,879.52 |
DisclosureSEC source: 0000905148-25-000872 · form4.xml · nonDerivative · entry 2 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 537,452 F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2024. F3 · price: Reflects a weighted average sale price of $32.6901 per share, at prices ranging from $31.925 to $32.91 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 21:20 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionAmerican Depositary Shares | 50,000 | $0.60 | $30,000.00 |
DisclosureSEC source: 0000905148-25-000872 · form4.xml · nonDerivative · entry 1 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 544,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 22:11 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionStock Options (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0000905148-25-000826 · form4.xml · derivative · entry 10 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 489,165 Underlying: American Depositary Shares · 50,000 shares Expires 2025-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The Stock Options fully vested as of October 22, 2020. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 22:11 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleAmerican Depositary Shares | 2,610 | $33.50 | $87,432.39 |
DisclosureSEC source: 0000905148-25-000826 · form4.xml · nonDerivative · entry 8 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 494,117 F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2024. F8 · price: Reflects a weighted average sale price of $33.499 per share, at prices ranging from $33.34 to $33.67 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 22:11 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleAmerican Depositary Shares | 24,280 | $32.99 | $801,014.20 |
DisclosureSEC source: 0000905148-25-000826 · form4.xml · nonDerivative · entry 7 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 496,727 F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2024. F7 · price: Reflects a weighted average sale price of $32.9907 per share, at prices ranging from $32.34 to $33.33 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 22:11 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleAmerican Depositary Shares | 23,110 | $31.75 | $733,693.97 |
DisclosureSEC source: 0000905148-25-000826 · form4.xml · nonDerivative · entry 6 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 521,007 F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2024. F6 · price: Reflects a weighted average sale price of $31.7479 per share, at prices ranging from $31.31 to $32.29 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 22:11 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionAmerican Depositary Shares | 50,000 | $0.60 | $30,000.00 |
DisclosureSEC source: 0000905148-25-000826 · form4.xml · nonDerivative · entry 5 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 544,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 22:11 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionStock Options (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0000905148-25-000826 · form4.xml · derivative · entry 9 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 539,165 Underlying: American Depositary Shares · 50,000 shares Expires 2025-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The Stock Options fully vested as of October 22, 2020. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 22:11 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleAmerican Depositary Shares | 200 | $35.06 | $7,011.00 |
DisclosureSEC source: 0000905148-25-000826 · form4.xml · nonDerivative · entry 4 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 494,117 F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2024. F5 · price: Reflects a weighted average sale price of $35.055 per share, at prices ranging from $35.05 to $35.06 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 22:11 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleAmerican Depositary Shares | 46,943 | $34.52 | $1,620,477.05 |
DisclosureSEC source: 0000905148-25-000826 · form4.xml · nonDerivative · entry 3 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 494,317 F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2024. F4 · price: Reflects a weighted average sale price of $34.5201 per share, at prices ranging from $34.04 to $34.99 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 22:11 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleAmerican Depositary Shares | 2,857 | $33.59 | $95,978.06 |
DisclosureSEC source: 0000905148-25-000826 · form4.xml · nonDerivative · entry 2 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 541,260 F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2024. F3 · price: Reflects a weighted average sale price of $33.594 per share, at prices ranging from $33.04 to $34.015 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 22:11 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionAmerican Depositary Shares | 50,000 | $0.60 | $30,000.00 |
DisclosureSEC source: 0000905148-25-000826 · form4.xml · nonDerivative · entry 1 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 544,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| December 11, 2024 Filed Dec 13, 2024 21:47 UTC | Zai Lab Ltd ZLAB · Entity 4271 | GiftAmerican Depositary Shares | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-003374 · form4.xml · nonDerivative · entry 1 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 494,117 F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · kind: This transaction represents a bona fide gift to a grantor retained annuity trust for which there is an independent trustee. Read SEC document |
| August 13, 2024 Filed Aug 19, 2024 20:46 UTC | Zai Lab Ltd ZLAB · Entity 4271 | GiftAmerican Depositary Shares | 87,793 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-002293 · form4.xml · nonDerivative · entry 1 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 994,117 F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · kind: This transaction represents a bona fide charitable contribution as a gift to a donor advisory fund. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:30 UTC | Zai Lab Ltd ZLAB · Entity 4271 | GrantRestricted Share Units · Derivative | 72,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-001830 · form4.xml · derivative · entry 4 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,000 Underlying: American Depositary Shares · 72,000 shares Expires not disclosed F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ADS. F7 · derivative.exercise_date: The RSUs vest in equal annual installments over four years beginning on 07/01/2025, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F7 · derivative.expiration_date: The RSUs vest in equal annual installments over four years beginning on 07/01/2025, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:30 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleAmerican Depositary Shares | 7,013 | $17.48 | $122,573.21 |
DisclosureSEC source: 0000905148-24-001830 · form4.xml · nonDerivative · entry 2 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,081,910 F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F5 · shares: These ADSs were sold automatically to cover taxes upon vesting of RSUs. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 20:30 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionRestricted Share Units · Derivative | 17,970 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-001830 · form4.xml · derivative · entry 3 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,910 Underlying: American Depositary Shares · 17,970 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ADS. F6 · derivative.exercise_date: The RSUs vest in equal annual installments over four years beginning on 06/29/2024, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F6 · derivative.expiration_date: The RSUs vest in equal annual installments over four years beginning on 06/29/2024, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 20:30 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionAmerican Depositary Shares | 17,970 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000905148-24-001830 · form4.xml · nonDerivative · entry 1 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,088,923 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · shares: ADSs acquired upon vesting of Restricted Share Units ("RSUs"). F3 · price: Each RSU represents a contingent right to receive one ADS. F4 · balance_after: This number reflects a net reduction of 71,880 ADSs, which represents RSUs that previously reported as aggregated with ADSs in Table I and are now separately reported in Table II. Read SEC document |
| June 26, 2024 Filed Jun 27, 2024 20:08 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleAmerican Depositary Shares | 23,939 | $17.90 | $428,532.04 |
DisclosureSEC source: 0000905148-24-001802 · form4.xml · nonDerivative · entry 2 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,142,833 F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F4 · shares: These ADSs were sold automatically to cover taxes upon vesting of RSUs. Read SEC document |
| June 25, 2024 Filed Jun 27, 2024 20:08 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionRestricted Share Units · Derivative | 58,800 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-001802 · form4.xml · derivative · entry 3 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,600 Underlying: American Depositary Shares · 58,800 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ADS. F5 · derivative.exercise_date: The RSUs vest in equal annual installments over four years beginning on 06/25/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F5 · derivative.expiration_date: The RSUs vest in equal annual installments over four years beginning on 06/25/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| June 25, 2024 Filed Jun 27, 2024 20:08 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionAmerican Depositary Shares | 58,800 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000905148-24-001802 · form4.xml · nonDerivative · entry 1 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,166,772 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F2 · shares: ADSs acquired upon vesting of Restricted Share Units ("RSUs"). F3 · price: Each RSU represents a contingent right to receive one ADS. Read SEC document |
| April 03, 2024 Filed Apr 5, 2024 21:47 UTC | Zai Lab Ltd ZLAB · Entity 4271 | GrantRestricted Share Units · Derivative | 27,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-001111 · form4.xml · derivative · entry 2 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,000 Underlying: American Depositary Shares · 27,000 shares Expires not disclosed F4 · derivative.exercise_price: Each Restricted Share Unit ("RSU") represents a contingent right to receive one ADS. F5 · derivative.exercise_date: The RSUs vest in equal annual installments over four years beginning on 04/03/2025, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F5 · derivative.expiration_date: The RSUs vest in equal annual installments over four years beginning on 04/03/2025, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F3 · derivative.underlying: Each ADS represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| April 03, 2024 Filed Apr 5, 2024 21:47 UTC | Zai Lab Ltd ZLAB · Entity 4271 | GrantStock Options (Right to Buy) · Derivative | 533,065 | $0.00 Strike: $16.18 | $0.00 |
DisclosureSEC source: 0000905148-24-001111 · form4.xml · derivative · entry 1 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 533,065 Underlying: American Depositary Shares · 533,065 shares Expires 2034-04-03 F1 · security: Each Stock Option is exercisable for one American Depositary Share ("ADS"), which represents ten Ordinary Shares of the issuer. F2 · derivative.exercise_date: The option vests in equal annual installments over four years beginning on 04/03/2025, the first anniversary of the date of grant, subject to continuous service. F3 · derivative.underlying: Each ADS represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. Read SEC document |
| April 02, 2024 Filed Apr 4, 2024 01:44 UTC | Zai Lab Ltd ZLAB · Entity 4271 | SaleAmerican Depositary Shares | 1,387 | $16.15 | $22,401.44 |
DisclosureSEC source: 0000905148-24-001092 · form4.xml · nonDerivative · entry 4 Du Ying · CIK 0001731790 · Director · Chairperson & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,107,972 F1 · security: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. F3 · shares: These ADSs were sold automatically to cover taxes upon vesting of Restricted Share Units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.